BARBANTI, FRANCESCA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 305
EU - Europa 192
AS - Asia 108
AF - Africa 8
Totale 613
Nazione #
US - Stati Uniti d'America 305
IT - Italia 63
SG - Singapore 50
SE - Svezia 33
DE - Germania 27
CN - Cina 23
GB - Regno Unito 23
IE - Irlanda 20
IN - India 17
BG - Bulgaria 10
JO - Giordania 10
FR - Francia 5
FI - Finlandia 4
ID - Indonesia 4
NG - Nigeria 3
CI - Costa d'Avorio 2
PK - Pakistan 2
AT - Austria 1
BE - Belgio 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
NO - Norvegia 1
RU - Federazione Russa 1
TG - Togo 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 613
Città #
Singapore 42
Chandler 40
Ashburn 30
Fairfield 28
Dublin 20
Southend 20
Seattle 16
Woodbridge 15
Princeton 14
Wilmington 14
Bologna 12
Amman 10
Sofia 10
Ann Arbor 9
Turin 9
Houston 8
Milan 7
Naples 6
Boardman 4
Cambridge 4
Des Moines 4
Helsinki 4
Redmond 4
San Francisco 4
Santa Clara 4
Abeokuta 3
Cesena 3
Jakarta 3
New York 3
Rome 3
San Diego 3
Abidjan 2
Berlin 2
Frattamaggiore 2
Fremont 2
Genoa 2
Hangzhou 2
Livorno 2
Lucknow 2
Medford 2
Munich 2
Norcross 2
Olalla 2
Rawalpindi 2
Rimini 2
Shanghai 2
Shenzhen 2
Bab Ezzouar 1
Beijing 1
Brussels 1
Casalecchio di Reno 1
Clearwater 1
Dongguan 1
Hendon 1
Hyderabad 1
Kiev 1
Lomé 1
London 1
Malang 1
Ningbo 1
Ostrava 1
Padova 1
Paris 1
Parma 1
Pune 1
Qingdao 1
Redwood City 1
Reggio Nell'emilia 1
Roccella Ionica 1
San Jose 1
Shenyang 1
Taipei 1
Taiyuan 1
Toulouse 1
Vancouver 1
Vienna 1
Westminster 1
Wuhan 1
Zhengzhou 1
Zurich 1
Totale 421
Nome #
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update 116
Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential 89
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations 85
Obesity and NAFLD: Same problem? 58
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 53
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 52
COMBINATION study: COMbined Behavioural/INcretin Action sTudy In Obese/diabetic persoNs 52
Prevalence of orthorexic traits in type 2 diabetes mellitus: at the crossroads between nutritional counseling and eating disorders 45
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 32
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 31
How much fat does one need to eat to get a fatty liver? A dietary view of NAFLD 21
Totale 634
Categoria #
all - tutte 2.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 5 4 6 2 0 2
2020/202177 2 2 0 0 0 45 0 3 11 6 0 8
2021/2022136 3 14 8 1 10 7 2 9 13 5 46 18
2022/2023193 9 13 9 14 16 22 12 13 56 3 13 13
2023/2024104 16 14 7 6 9 22 2 13 7 5 2 1
2024/2025105 15 45 32 13 0 0 0 0 0 0 0 0
Totale 634